WASHINGTON, DC - September 9, 2014 - Transcatheter Cardiovascular Therapeutics 2014 (TCT) will feature a number of sessions and presentations focusing on women in healthcare and interventional cardiology. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
"This year's TCT showcases just some of the current and future initiatives aimed at improving the medical treatment of women with cardiovascular disease," said Roxana Mehran, MD. Dr. Mehran is Chief Scientific Officer of the CRF Clinical Trials Center and a Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). She is also Professor of Medicine at Mount Sinai School of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute.
"We are also very excited to honor Dr. Marie Claude Morice as the first woman to be given the TCT Master Operator Award, as well as raise awareness of the importance of increasing the quality of professional opportunities for female interventional cardiologists," Dr. Mehran added.
The sessions and presentations featuring women in cardiology include the following:
Saturday, September 13
Hot Topic Lunch: Developments in Accountable Care in China
12:15 PM - 1:45 PM
Tsung-Mei Cheng, an expert on comparative health systems in Asia, from Princeton University will lead a special lunch session on healthcare reform in China and the United States.
The Society of Cardiovascular Angiography and Intervention's (SCAI) Women in Innovations (WIN) Reception
6:00 PM - 8:00 PM
Acadiana Restaurant (901 New York Ave NW)
Dr. Cindy Grines, current Chair of SCAI WIN and Dr. Roxana Mehran, founder of SCAI WIN, along with distinguished female interventionalists from around the world will share their perspectives on how women can influence the interventional space.
Sunday, September 14
TCT 2014 Geoffrey O. Hartzler Master Operator Award
10:45 AM - 11:00 AM
Main Arena (Level 3, Ballroom)
Marie Claude Morice, MD will be presented the TCT 2014 Geoffrey O. Hartzler Master Clinical Operator Award. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and innovation. Dr. Morice, a world-renowned interventional cardiologist, is the first woman to be recognized with this award.
Featured Clinical Research: Women in Interventional Cardiology: Update in PCI Practice Patterns and Outcomes From the National Cardiovascular Data Registry
12:15 PM - 12:30 PM
Room 103 A
A retrospective study presented by Dr. Cindy L. Grines of more than 2.4 million percutaneous coronary interventions (PCI) performed in 1,431 U.S. hospitals. The study examines the practice patterns and outcomes of PCI procedures performed by female interventional cardiologists.
Monday, September 15
TAVR in Women: The Present and the Future
6:30 AM - 8:00 AM
Sponsored by SCAI, this breakfast symposia will examine female data and implications from trials of patients undergoing transcatheter aortic valve implantation.
Dr. Roxana Mehran and the other TCT faculty and participants are available for interviews. Please contact Judy Romero to coordinate.
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with heart disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world's premier educational meeting specializing in interventional cardiovascular medicine. For more than 25 years, TCT has featured major medical research breakthroughs and gathered leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.